The global respiratory care device market reached a value of around USD 23.53 Billion in 2025, fuelled by the rise in severe respiratory diseases across the globe. The market is expected to grow at a CAGR of 8.60% during the forecast period of 2026-2035 and expected to attain a market value of around USD 53.69 Billion by 2035.
Base Year
Historical Period
Forecast Period
The market for respiratory care devices is expanding as a result of the rise in respiratory disorders. Lung cancer and other serious respiratory disorders are on the rise as a result of sedentary lifestyles and demanding schedules, along with the increased rates of smoking and alcohol intake.
The respiratory care device market is anticipated to benefit from governmental and non-profit initiatives, like the Global Initiative for Asthma (GINA), several awareness campaigns, funding for research to make high-quality healthcare facilities available to everyone, along with the formation of new and improved healthcare infrastructure.
The rise in the elderly population and the frequency of preterm births are also influencing the need for respiratory care devices.
Compound Annual Growth Rate
8.6%
Value in USD Billion
2026-2035
*this image is indicative*
Respiratory devices refer to equipment used in the medical field to assist people with breathing complications. These include medical oxygen concentrators, nebulizers, and ventilators. It works to help patients with various respiratory diseases like chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), fibrosis, and asthma.
The market is driven by increasing prevalence of respiratory conditions, leading to heightened use of such devices. The sudden outbreak of COVID-19 also impacted the market significantly and led to a higher demand for personal protective equipment (PPE) and ventilators.
Burgeoning Cases of Respiratory Illnesses are Expected to Drive the Market Growth
COPD and asthma are common respiratory illnesses that increasing globally. The rising incidence of such diseases has raised the need for respiratory monitoring equipment significantly. As a result, Advancements have been made in portable nebulizers and smart inhalers. Such advancements can help patients follow the treatment plan as well as improve outcomes. Rising awareness of respiratory health and global aging also boosts demand for these devices.
Technological Advancements Boosts the Market Growth
The advancement of technology plays a crucial role in the global market. Some innovations in respiratory care have boosted patient care and healthcare delivery. They include better ventilators, nebulizers, and portable oxygen concentrators. AI and machine learning are becoming more important in diagnosing respiratory diseases. They can improve the patient’s experience by enabling better healthcare processes and decision support. This support can offer more accurate and personalized treatment suggestions. So, these technologies are driving market growth.
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
In March 2024, Medline, a well-established supplier of medical equipment and solutions, won the license for AG Cuffill and intellectual properties from Hospitech Respiration Ltd. AG Cuffill is a small easy-to-use device and measures the pressure and volume of airway cuffs consistently in clinical practice. This move expands Medline’s product offering and aims to help healthcare professionals track airway cuffs. This will reduce medical adverse effects and improve individual situations.
In February 2024 -Aircurve 11 series of ResMed utilized inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP) along with digital features. Such innovative designs are especially valuable for healthcare practitioners and patients, making it easier to diagnose and treat sleep apnea. This device has better features and navigation, which will improve therapy benefits and increase satisfaction in sleep apnea.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
"Respiratory Care Device Market Report and Forecast 2026-2035" offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Disease Indications
Market Breakup by End User
Market Breakup by Region
Market Share by Product Type Poised for Growth
Based on the product, the market is further segmented into therapeutic respiratory care devices (positive airway pressure (PAP) devices, oxygen concentrator, ventilators, inhalers, nebulizers, humidifiers, reusable resuscitators, nitric oxide delivery units and oxygen hoods), along with respiratory care monitoring devices (pulse oximeter, capnography, gas analyzers) and diagnostic respiratory care devices (spirometer, polysomnography devices, peak flow meter, others). Out of these therapeutic applications, inhalers, ventilators, and nebulizers are some of the key monitoring devices that dominate the market because of application in COPD and asthma treatment.
Self-usage inhalers and nebulizers are now more accessible globally. They meet the needs of aging people and the rise of chronic respiratory diseases. They allow for easy drug and protein delivery to the lungs. Other products, like pulse oximeters and gas analyzers, are also poised to experience growth. This can be due to their non-invasive respiratory health checks and accurate data tracking.
Market Segmentation Based on the Disease Indications Set to Drive Market Growth
Based on disease indications, the market is further segmented into COPD, asthma, sleep apnea, infectious diseases, and others. Among these, COPD stands out as the predominant segment and is the third-largest cause of death globally. Cigarette smoking remains the leading cause of COPD, with at least 70% of patients worldwide affected by it. Around 30-40% of affected individuals are present in low- and middle-income countries (LMICs). Household pollution also adds to the problem and lead to growth in COPD cases. Respiratory care devices actively help healthcare systems worldwide to meet the needs of patients with COPD and other respiratory disorders, leading to continuous market growth.
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa are all included in the regional market analysis. North America is expected to dominate the market because of its strong healthcare system, rising respiratory disorders, and increased use of advanced technologies. This leadership is supported by ongoing research and a proactive approach to utilizing better respiratory care solutions. In addition, the region offers strategic pro-employer reimbursement policies. However, the Asia Pacific region is likely to register noticeable growth in the forecast period. Rising awareness of respiratory health, high health costs, and population growth are major factors impacting the market value. The development of various healthcare facilities in emerging economies like India and China will boost the adoption of advanced respiratory care devices, creating new opportunities for regional expansion.
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives including recent partnerships, and collaborations between the leading players. The major companies in the market are as follows:
The Eindhoven-based company started its journey in 1891. It is an innovative company in respiratory care devices and sleep apnea therapies. Their products and services include the number of ventilators including the V60 Plus ventilator, Trilogy EV 300 ventilator, etc.
Founded in 1989 and based in California, U.S. This company offers different respiratory care devices and technologies for hospitals. Their products include pulse oximeters, pulse co-oximeters, and rainbow acoustic monitoring.
It is American company established in 1943 and headquartered in Pennsylvania. It specializes in providing medical equipment for critical care and surgery procedures. The company focuses on researching, developing, manufacturing, and marketing disposable medical technology products.
Based in East Tamaki, Auckland, this company was established in 1934. The company offers various respiratory devices such as AirVO2, CPAP, etc.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies in the market include Hamilton Medical AG, ICU Medical Inc., General Electric Company, ResMed Inc., Getinge AB, Aerin Medical Inc., and VitalAire Canada Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Disease Indications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share